Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
293 17 0 PSTI
Emcee:  FUBHO Type:  Moderated
Pluristem Life Systems, Inc. (OTCBB PLRS): aims to become a leader in stem cell expansion, specializing initially in hematopoietic stem cells, using its unique 3-D technology platform and proprietary PluriX™ bioreactor. Similarly, the Company will further develop its exclusive stromal cell expression libraries, which are expected to boost bone marrow transplants and significantly improve their success rate while maximizing immune system functioning.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
293 PSTI reports positive top line results. PLX-PAD treatment reduced risk of revaACAN-June 12
292 PSTI HAIFA, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Pluristem TherapeuticsACAN-June 4
291 PSTI April 30 FDA clears Pluristem radiation treatment for emergency use BACAN-April 30
290PSTI chart looks to be responding well to latest news, and good volume setting uACAN-April 25
289is there anyone out there that owns psti that would like to share or talk about thesaud-April 7
288On watch for clear above 2.02. [graphic]hollyhunter-10/23/2017
287Securities and Exchange Commission v. Jason Napodano, Bilal Basrai and Bryce StiStockDung-9/27/2017
286PLX-R18 Heals 100% of Population Exposed To Lethal Radiation through Nuclear AccFUBHO-3/9/2016
285Bullish cross in MACD and Stochastic oscillator according to foxchart. On watch sfnsie-12/5/2015
284Israeli biotech firm to test radiation therapy in Fukushima JERUSALEM, Dec 3 (FUBHO-12/3/2015
283DoneSI Ron (Soup Nazi)-6/1/2015
282Did xcentral respond to this request? I will moderate if nobody responded...FUBHO-6/1/2015
281Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel Company FUBHO-6/1/2015
280Does anyone want to moderate this board?SI Ron (Soup Nazi)-1/28/2015
279New Published Data Show Pluristem's PLX Cells Protect Neurons PLX Cells CoFUBHO-1/2/2015
278Phase I/II trial in the treatment of muscle injury met primary safety & effidos21/21/2014
2779:29 am Pluristem Therapeutics: results of co's Phase I/II muscle injury triFUBHO-1/6/2014
276Positive Data From the First Study Prompts Decision HAIFA, Israel, Jul 18, 2013xcentral1-7/18/2013
275ps - IMHO - I think that the alliance with Cha in South Korea is "Brilliantxcentral1-7/11/2013
274Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial Study Conducxcentral1-7/11/2013
273About that "Clinical-Hold" ... IMHO 1 - Aberman is dead serious abouxcentral1-7/9/2013
272Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells Hxcentral1-7/9/2013
271Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bioxcentral1-7/9/2013
270Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journxcentral1-7/9/2013
269Pluristem Provides Update on Clinical Status of IC Trials HAIFA, Israel, Jun 1xcentral1-7/9/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.